We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 5EA market cap is 5.68B. The company's latest EPS is USD -2.4901 and P/E is -4.79.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.07B | 3.28B | 4.77B | 4.41B | 4.42B |
| Operating Income | 174.3M | -696.1M | -48M | 201M | -817M |
| Net Income | 67.9M | -560.1M | -472M | -78M | -1.23B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.99B | 17.69B | 16.48B | 15.49B | 14.36B |
| Total Liabilities | 3.44B | 9.22B | 8.95B | 8.2B | 8.14B |
| Total Equity | 5.55B | 8.48B | 7.54B | 7.29B | 6.22B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 224.1M | -41M | 483M | 452M | 271M |
| Investing | -234.8M | -4.78B | -530M | -179M | -169M |
| Financing | -304.8M | 4.95B | 210M | -549M | -83M |
| Market Cap | 5.68B |
| Price to Earnings Ratio | -4.79 |
| Price to Sales Ratio | 1.33 |
| Price to Cash Ratio | 16.74 |
| Price to Book Ratio | 0.95 |
| Dividend Yield | - |
| Shares Outstanding | 494.35M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.12 (1.07%) |
| Company Name | Elanco Animal Health Inc |
| Address |
135 north pennsylvania street indianapolis, indiana 46204 |
| Website | https://www.elanco.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
